Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy
HTML
Details
Locations
Year:
2026
Type:
review
Source:
Clinical & Translational Oncology
DOI:
10.1007/s12094-025-04213-4
Authors:
Nada Khairi Younis,
Ali Fawzi Al-Hussainy,
S. Renuka Jyothi,
Priya Priyadarshini Nayak,
J. Bethanney Janney,
Gurjant Singh,
Djamila Polatova,
Hayder Naji Sameer,
Rasim M. Salih,
Mohaned Adil
show all 10
Institutions:
Ahl Al Bayt University,
Jain University,
Siksha O Anusandhan University,
Institute of Medical Sciences and Sum Hospital,
Sathyabama Institute of Science and Technology,
Chandigarh University,
National University of Science and Technology,
Al-Zahrawi University,
Al-Farahidi University
show all 9
Language:
English
Topic:
Cancer Immunotherapy and Biomarkers
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
CTLA-4,
prostate cancer,
immune checkpoint inhibitors,
immunotherapy,
anti-CTLA-4 monoclonal antibody,
T cell regulation,
tumor immunosuppression
show all 7
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W7127038530
FWCI:
0.746
Cites:
143
Cited by:
1
Related to:
10